CDD3506 |
| Katalog-Nr.GC31460 |
CDD3506 wird zur ErhÖhung des High-Density-Lipoprotein-Cholesterins (HDL) durch Induktion der hepatischen Cytochrom-P450IIIA-AktivitÄt (CYP3A) verwendet.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 197913-15-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
CDD3506 is used for elevating high density lipoprotein cholesterol (HDL) by inducing hepatic cytochrome P450IIIA (CYP3A) activity.
CDD3506 specifically induces hepatic cytochrome P450IIIA produces significant increases in HDL cholesterol[1].
[1]. Method for increasing HDL cholesterol levels using heteroaromatic phenylmethanes. United States Patent 6103733
Average Rating: 5 (Based on Reviews and 26 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *